Related by context. All words. (Click for frequent words.) 72 Stage IIIA 61 stage IIIB 58 recurrent NSCLC 58 unresectable stage 57 Stage IIB 57 histologically confirmed 56 mRCC 56 IIIa 56 MabCampath 56 stage IIIb IV 56 Castration Resistant Prostate Cancer 56 mildly symptomatic 56 PEG IFN 56 unresectable Stage III 55 rotigotine transdermal patch 55 paclitaxel carboplatin 55 IV NSCLC 55 IIIA NSCLC 55 metastatic gastric 55 IV melanoma 55 follicular lymphoma FL 55 chemoradiation therapy 54 inhaled AAT 54 biliary tract cancer 54 CTEPH 54 5 fluorouracil leucovorin 54 Lenalidomide 54 non splenectomized 54 completely resected 54 cinacalcet 54 Yondelis ® 54 castrate resistant 54 tocilizumab 54 TORISEL 54 IBS C 54 ER CHOP 54 Betaferon R 54 paclitaxel poliglumex 54 TEMODAL 54 Relapsed Multiple Myeloma 54 multicenter phase 54 Stage IIIb 53 relapsing remitting MS RRMS 53 IIIB 53 Decitabine 53 recurrent metastatic 53 genotype 1a 53 Temsirolimus 53 evaluating Prochymal 53 Adjuvant Treatment 53 Hsp# Inhibitor 53 leukemia AML 53 selective A2A adenosine receptor 53 COPERNICUS 53 CIMZIA TM 53 refractory chronic lymphocytic 53 fluoropyrimidine 53 somatostatin analog 53 Hexvix ® 53 Randomized Phase II 53 surgically resectable 53 stage IIIb 53 Acute Myeloid Leukemia AML 53 severe oral mucositis 53 IIIb 53 Interferon alfa 53 relapsing multiple sclerosis 53 advanced pancreatic neuroendocrine 53 4mg/kg 53 Fludarabine 53 5-FU/LV 53 Degarelix 53 Capecitabine 53 Follicular Lymphoma 53 omacetaxine mepesuccinate 53 TG# [001] 52 urothelial bladder cancer 52 Hormone Refractory Prostate Cancer 52 Patients Treated With 52 metastatic colorectal 52 Prolongs Survival 52 STRIDE PD 52 recurrent glioblastoma multiforme 52 medically inoperable 52 chronic idiopathic thrombocytopenic purpura 52 nonmetastatic 52 rilonacept 52 Relapsing Remitting Multiple Sclerosis 52 stage IIIA 52 advanced hepatocellular carcinoma 52 Pivotal Trial 52 Meets Primary Endpoint 52 CRp 52 Pemetrexed 52 Roche MabThera 52 receptor tyrosine kinase inhibitor 52 Vekacia R 52 Initiate Phase 52 Soft Tissue Sarcoma 52 IIIA 52 assessing T DM1 52 untreated multiple myeloma 52 EOquin TM 52 resectable 52 Arranon 52 CLL SLL 52 metastatic pancreatic 52 Dacogen TM 52 ZACTIMA 51 docetaxel Taxotere ® 51 beta 1a 51 Chemoradiation 51 YONDELIS 51 Orphan Medicinal Product 51 CAELYX 51 pT3 51 Relapsed Refractory 51 gemcitabine carboplatin 51 ara C 51 volociximab 51 tumor xenograft models 51 underwent resection 51 colorectal metastases 51 Cimzia ® certolizumab pegol 51 multiple myeloma MM 51 recurrent colorectal cancer 51 GW# [003] 51 ZYBRESTAT TM 51 tumors GIST 51 surgically resected 51 Cinacalcet HCl 51 Dacogen injection 51 LymphoStat B belimumab 51 saphenous vein graft 51 relapsed MM 51 Mantle Cell Lymphoma 51 external beam radiotherapy 51 piperacillin tazobactam 51 Achieves Primary Endpoint 51 Monotherapy 51 Initiated Phase 51 NMIBC 51 aplastic anemia AA 51 MKC# MT 51 Clevudine 51 generation purine nucleoside 51 NAVISTAR R 51 multicenter randomized controlled 51 riociguat 51 stereotactic radiotherapy 51 Gastrointestinal Stromal Tumors 51 CYT# potent vascular disrupting 51 Pivotal Phase 51 Initiate Clinical Trial 51 Randomized Study 51 haematologic 51 otamixaban 51 Cyclophosphamide 51 Myozyme ® alglucosidase 50 pT2 50 Raptiva R 50 Randomized Phase 50 Ozarelix 50 cytoreductive nephrectomy 50 Severe Sepsis 50 CML CP 50 prostate carcinoma 50 metastatic bladder 50 SIR Spheres 50 HoFH 50 malignant ascites 50 Intravitreal 50 MKC# 50 metastatic GIST 50 peritoneal carcinomatosis 50 vinorelbine tartrate 50 stated Michelle Berrey 50 huN# DM1 50 cinacalcet HCl 50 fosbretabulin 50 locoregional 50 Advanced Melanoma 50 ® lenalidomide 50 hepatocellular carcinomas 50 Hepatocellular Carcinoma HCC 50 autologous SCT 50 Xanafide 50 hepatorenal syndrome 50 Apoptone 50 nonsmall cell lung cancer 50 Neoadjuvant 50 FOLFOX6 50 KN# [001] 50 rindopepimut 50 UPLYSO 50 colorectal carcinomas 50 concurrent chemoradiation 50 radiotherapy RT 50 Myelodysplastic Syndrome MDS 50 Kahalalide F 50 small molecule tyrosine 50 TASQ 50 Epratuzumab 50 metastatic malignant 50 gastrointestinal toxicities 50 Gemcitabine 50 Oral Fingolimod 50 BENICAR HCT 50 Xelox 50 MVA MUC1 IL2 50 Pivotal Phase II 50 IVa 50 Proxinium TM 50 Interferon Alfa 50 Cimzia TM 50 Iluvien TM 50 NYHA Class III 50 Cloretazine 50 ACOMPLIA R 50 SHPT 50 Posaconazole 50 glatiramer acetate GA 50 PSMA ADC 50 advanced medullary thyroid 50 Azacitidine 50 metastatic hormone refractory 50 ACZ# 50 refractory NSCLC 50 monoclonal antibody conjugated 50 targeting miR 50 histologies 50 Telatinib 50 g dl 49 Romiplostim 49 baminercept 49 crossclamp 49 Recurrent Glioblastoma 49 Melphalan 49 underwent surgical resection 49 non squamous 49 Aflibercept 49 metastatic renal 49 Peginterferon Alfa 2a 49 Orphan Designation 49 romiplostim 49 XIENCE TM 49 LHRH receptor positive 49 HuMax EGFr 49 Metastatic Renal Cell Carcinoma 49 pancreatic carcinoma 49 transdermal estradiol 49 metastatic neuroendocrine tumors 49 Dacogen decitabine 49 recurrent glioblastoma 49 Plaque Psoriasis 49 Safinamide 49 corticosteroid dexamethasone 49 hereditary deficiency 49 weekly subcutaneous injections 49 dacarbazine DTIC 49 Ibritumomab Tiuxetan 49 TAXUS Liberté stent 49 chronic ITP patients 49 azacytidine 49 dasatinib Sprycel 49 Evoltra 49 Bayer HealthCare Onyx Pharmaceuticals 49 antiangiogenic agent 49 adjuvant trastuzumab 49 Pfizer Camptosar 49 pegaptanib 49 Is Well Tolerated 49 NYHA Class II 49 dirucotide MBP# 49 EGFR HER2 49 gastrointestinal stromal tumors GIST 49 Efficacy Trial 49 CEQ# 49 Commences Phase 49 Pharmacokinetics PK 49 Acute Ischemic Stroke 49 MabThera Rituxan 49 Elitek 49 Commence Phase 49 chronic thromboembolic pulmonary 49 gemcitabine Gemzar ® 49 EndoTAG TM -1 49 ankylosing spondylitis AS 49 liposomal amphotericin B 49 Pertuzumab 49 dimeglumine 49 Survival Benefit 49 recurrent squamous cell carcinoma 49 Bosentan 49 RhuDex ® 49 teriflunomide 49 GORE TAG Device 49 colorectal carcinoma 49 mineralocorticoid receptor 49 Antitumor Activity 49 Familial Hypercholesterolemia 49 EHEDG 49 Radiofrequency Ablation RFA 49 Prospective Randomized 49 non splenectomised 49 decitabine 49 Diamyd ® 49 biologic DMARD 48 Solid Tumours 48 RECIST criteria 48 mL/min/#.# m 2 48 #ug [002] 48 dose escalation phase 48 thrombocytopenic 48 fistulizing Crohn disease 48 EDSS score 48 Peg IFN 48 Cypher Stent 48 terlipressin 48 Removab 48 Nebulized 48 Amgen Neulasta ® 48 VIAject ™ 48 SSc 48 CsA 48 ASCT 48 orphan designation 48 injected subcutaneously 48 deferoxamine 48 ChronVac C ® 48 PF # [002] 48 mutated K ras 48 baseline LDH 48 metastatic ovarian cancer 48 Platinol ® 48 elevated LDH 48 oncolytic vaccine 48 eltrombopag 48 Harry Palmin President 48 IV metastatic melanoma 48 Metastatic Pancreatic Cancer 48 unresectable tumors 48 Systemic Sclerosis 48 primary humoral immunodeficiency 48 Vidofludimus 48 Accelerated Partial Breast Irradiation 48 idarubicin 48 Dasatinib 48 Xyrem ® 48 oral Hycamtin 48 histologic subtype 48 RhuDex TM 48 Thrombolysis 48 Advanced Renal Cell 48 FOLFOX4 48 Angiox R 48 Topotecan 48 levodopa induced dyskinesia 48 inotropic therapy 48 Omacetaxine 48 oral treprostinil 48 tenecteplase 48 B#.# [001] 48 Critical Limb Ischemia CLI 48 CIMZIA R 48 DOXIL 48 papillary renal cell carcinoma 48 mITT population 48 Leucovorin 48 aggressive systemic mastocytosis 48 Percutaneous Transluminal Coronary Angioplasty 48 Silodosin 48 Evoltra ® 48 biventricular 48 intra arterial 48 Acute Myeloid Leukemia 48 continuous intravenous infusion 48 galiximab 48 5alpha reductase 48 TO AVOID PREGNANCY WHILE 48 antibiotic amikacin 48 Inhaled AAT 48 immunomodulatory therapy 48 Trabectedin 48 Epirubicin 48 Myelodysplastic Syndromes 48 Pegylated Liposomal Doxorubicin 48 Etanercept 48 Dose Ranging Study 48 miconazole Lauriad ® 48 Diamyd r 47 tumor necrosis 47 R adalimumab 47 active ankylosing spondylitis 47 Tumor Necrosis Factor 47 Receptor Antagonists 47 Antitumor 47 Sanvar R 47 essential thrombocythemia ET 47 adriamycin 47 VARIVAX 47 GALNS 47 Lymphocytic 47 Cutaneous T 47 Surgical resection 47 neurological manifestations 47 dose melphalan 47 pancreatic adenocarcinoma 47 Pharmacodynamics 47 total thyroidectomy 47 efaproxiral 47 CIMZIA ™ 47 HIV HCV coinfected 47 PAOD 47 Occlusive Disease 47 Balloon Catheters 47 abacavir Ziagen 47 erlotinib Tarceva ® 47 Parathyroid Hormone 47 AST ALT 47 RhuDex R 47 Severe VOD 47 Intra arterial 47 Alphanate R 47 HBeAg negative 47 #Gy 47 RENAL 47 ISTODAX 47 PROSTVAC ® 47 Resection 47 renal artery stenting 47 Chronic HCV 47 Novel Oral 47 Study Evaluating 47 ALN HPN 47 chronic immune thrombocytopenic 47 Metastatic Melanoma 47 Troxatyl 47 Certolizumab pegol 47 Acute Myelogenous Leukemia AML 47 gefitinib Iressa 47 Adjuvant Therapy 47 Valvular 47 postoperative chemotherapy 47 International Prognostic Scoring 47 Cystectomy 47 Hepatocellular Carcinoma 47 bortezomib Velcade 47 HYCAMTIN 47 p# biomarker 47 DP b# 47 anti angiogenic agents 47 T1c 47 tumor lysis syndrome 47 DEB# 47 Oropharyngeal Candidiasis 47 Angiox ® 47 eculizumab 47 mycophenolate mofetil 47 Diabetic Retinopathy DR 47 ß blockers 47 HCV Genotype 47 macrolide antibiotic 47 Factor VIIa 47 TEMODAR 47 UCB Keppra 47 Orally Active 47 Retreatment 47 Virulizin R 47 Malignant Melanoma 47 AMPLATZER R 47 hGH CTP Phase 47 SCr 47 Angiotensin Converting Enzyme 47 Bevacizumab 47 Vascugel ® 47 concurrent chemoradiotherapy 47 Carboplatin 47 intravesical chemotherapy 47 liver resection 47 treat chronic sinusitis 47 urothelial carcinoma 47 anaplastic astrocytomas 47 Erlotinib 47 Metastatic Prostate Cancer 47 Infusion Reactions Severe 47 Chronic lymphocytic leukemia CLL 47 B#.# [002] 47 IIb 47 bleomycin 47 interferon ribavirin 47 Archexin 47 patientswith 47 romidepsin 47 Glioblastoma Multiforme 47 tiuxetan 47 Janus kinase 47 vismodegib 47 basal cell carcinoma BCC 47 unfractionated heparin UFH 47 HCl capsules 47 Anti VEGF 47 Adjuvant chemotherapy 47 transthoracic 47 MARPOL Annex 47 myelodysplastic syndrome MDS 47 PROMACTA 47 Hb A1C 47 alpha1 antitrypsin deficiency 47 Adjuvant Chemotherapy 47 Lenocta 46 Rotigotine 46 biologic antibody 46 Alkeran 46 papillary RCC 46 Congenital Emphysema 46 hypereosinophilic syndrome 46 Stereotactic Body Radiation Therapy 46 Uvidem 46 bronchoalveolar lavage 46 ATIR 46 node dissection 46 Enzyme Replacement Therapy 46 Naive Patients 46 Eniluracil 46 Mycophenolate Mofetil 46 TASKi3 46 p#HER# positive 46 Pralatrexate 46 Talotrexin 46 Peripheral Arterial 46 plus 5-FU/LV 46 Glivec imatinib 46 diagnosing coronary artery 46 medullary thyroid carcinoma 46 Anaplastic 46 ABVD 46 Myelodysplastic Syndrome 46 intraepithelial neoplasia 46 Tumor Response 46 vinca alkaloid 46 multicentre phase 46 F FDG PET 46 ReN# 46 predominantly classic subfoveal 46 acute peripheral arterial 46 nodal metastasis 46 antiangiogenic therapy 46 levodopa induced 46 RTCA DO #B 46 cancer mCRC 46 BEXXAR Therapeutic Regimen 46 Aplidin R 46 conformal radiotherapy 46 neoplasia CIN 46 Interferon beta 46 Platinol ® cisplatin 46 DNA intercalator 46 JAK2 V#F 46 hematologic toxicity 46 GVAX Pancreas Vaccine 46 thymoma 46 NSABP B 46 Secondary Hyperparathyroidism 46 confirmatory Phase 46 K ras mutations 46 First Patient Dosed 46 novel synthetic peptide 46 NovoSeven ® 46 cutaneous squamous cell carcinoma 46 anaplastic astrocytoma 46 recombinant tissue plasminogen 46 Dry Powder Inhalers 46 fallopian tube carcinoma 46 palliative radiotherapy 46 antiarrhythmic drugs 46 intraperitoneally 46 lymphadenectomy 46 occlusion PAO 46 Gleevec imatinib mesylate 46 Mipomersen 46 myeloproliferative disorder 46 CBLC# 46 chemotherapy cisplatin 46 PKC# 46 humanised antibody 46 PEGylated interferon 46 Metered Dose Inhalers MDIs 46 IONSYS TM 46 Nilotinib 46 Glioblastoma Multiforme GBM 46 undergoing radical cystectomy 46 complement inhibitor eculizumab 46 Exelixis XL# 46 including eniluracil ADH 46 Chronic Myelogenous Leukemia 46 bavituximab monotherapy trial 46 Pooled Analysis 46 Randomized phase 46 Eli Lilly Gemzar 46 variceal hemorrhage 46 malignant pleural mesothelioma 46 MoxDuo R 46 adjuvant radiotherapy 46 Ziprasidone 46 anaplastic astrocytoma AA 46 GLP1 agonist 46 adefovir treated 46 bolus injection 46 EGS# 46 Zebinix R 46 colorectal cancer liver metastases 46 glioblastoma GBM 46 metastatic malignant melanoma 46 Fludara ® 46 Lomitapide 46 rosuvastatin #mg 46 thalidomide Thalomid 46 Secretase 46 Chronic Renal Failure 46 Fx #A 46 pulmonary metastases 46 Shows Efficacy 46 mycophenolate mofetil MMF 45 HBeAg positive chronic hepatitis 45 Tigecycline 45 oral transmucosal fentanyl citrate 45 failure NYHA 45 AERx R 45 ACCLAIM COPD 45 Anticoagulant 45 Squamous Cell Carcinoma 45 Onalta TM 45 serum aminotransferase levels 45 intramuscular IM injection 45 LHON 45 Immunotherapeutic 45 MVax 45 Rate ORR 45 Vimpat R 45 mild hepatic impairment 45 Natalizumab 45 intestinal mucosal 45 Interreg 45 radical cystectomy 45 SYN# 45 esophageal carcinoma 45 Interferon Gamma 45 metered dose inhaler MDI 45 refractory anaplastic astrocytoma 45 REUTERS Claro Cortes 45 Immunosuppression 45 intratumoral 45 non nucleoside 45 GSTP1 45 Familial Adenomatous Polyposis 45 implantable centrifugal rotary 45 systemic hypotension 45 intravenous immunoglobulin IVIG 45 Ischemic 45 FDG PET scans 45 Otelixizumab 45 SANVAR 45 ANTEGREN 45 BRAF V#E 45 bearingless fully magnetically levitated 45 R Saizen R 45 LHRH agonists 45 plasmid encoding 45 Pulmonary Arterial Hypertension 45 Epidermal Growth Factor Receptor 45 OncoVAX ® 45 HeartMate R 45 PegIFN RBV 45 cytotoxic therapies 45 Treprostinil 45 metastatic androgen independent 45 NYHA Class 45 Infarct 45 Mitomycin C 45 Janus Kinase 45 gallium nitrate 45 MPS VI 45 Motexafin Gadolinium 45 Orally administered 45 recurrent glioma 45 hormone refractory metastatic prostate 45 recurrent endometrial cancer 45 familial amyloidotic polyneuropathy FAP 45 FDG PET imaging 45 Oncoscience AG 45 cytologically confirmed 45 kidney urologic 45 Trovax 45 NTx TM -# 45 ACE Inhibitor 45 Sorafenib 45 fentanyl citrate C 45 Twinrix 45 NYHA 45 Fabry Disease 45 hemoglobin hematocrit 45 Renal Function 45 Catheter Ablation 45 allogeneic stem cell 45 Shows Promise Against 45 epithelial ovarian 45 Roflumilast 45 ® daptomycin 45 CALGB # [002] 45 esophagogastric 45 steroid refractory GvHD 45 Chronic Sinusitis 45 KRAS mutation 45 ng dL 45 Androgel R 45 platelet aggregation inhibitor 45 Rilonacept 45 AZILECT R 45 malignant pancreatic 45 biliary stones 45 Zebinix 45 grade squamous intraepithelial 45 tyrosine kinase inhibitors TKIs 45 mSEPT9 biomarker 45 Improves Survival 45 novel vascular disrupting 45 recombinant Factor 45 Carbidopa Levodopa 45 Jetstream G2 45 recurrent glioblastoma multiforme GBM 45 Ganciclovir 45 Sapacitabine 45 histological subtype 45 APF# Phase 45 Unresectable 45 leuprolide acetate 45 mu g 45 Orphan Drug 45 benign prostatic hypertrophy BPH 45 Disease Progression 45 aurora kinase 45 TORISEL TM 45 NPM1 mutation 45 debulking surgery 45 colorectal adenoma 45 COPAXONE 45 Acute Myeloid Leukaemia AML 45 System IPSS 45 Myeloma Patients 45 severe gastroparesis 44 nonischemic 44 multicenter dose escalation 44 Velcade bortezomib 44 Elderly Patients 44 sodium thiosulfate STS 44 LUMINATE 44 thrombocytopenic patients 44 IIIc 44 CALGB 44 duplex ultrasonography 44 glycopeptide 44 Fondaparinux 44 ZOLINZA 44 activating mutation 44 neoplasias 44 corticosteroid therapy 44 mCi 44 Pretreatment 44 transarterial 44 pancrelipase 44 Teriflunomide 44 calcineurin inhibitors 44 Cimzia ® 44 immune thrombocytopenic purpura ITP 44 Aurora Kinase 44 albiglutide currently 44 Lymphoid 44 Moxifloxacin 44 DYNEPO 44 efalizumab 44 argatroban 44 TheraCIM h R3 44 Nucleoside 44 steroid refractory ulcerative 44 Patients Receiving 44 Amgen Neulasta R 44 NTx ® -# 44 grade cervical intraepithelial 44 alpha1 44 multimodality therapy 44 receptor antagonism 44 standard chemotherapy regimens 44 Radezolid 44 Androgen Deprivation Therapy 44 B Cell Lymphoma 44 Prostatic 44 M#V 44 labial herpes 44 Papillary 44 nonresponders 44 Carcinoma 44 liver histology 44 PTK# 44 prospective multicenter study 44 bronchial hyperresponsiveness 44 ENGAGE AF TIMI 44 pmol liter 44 Novel Small Molecule 44 immune thrombocytopenic purpura 44 adverse cytogenetics 44 Viral Load 44 Aggrastat ® tirofiban hydrochloride 44 RhD positive 44 Insulins 44 ARC# [001] 44 urothelial cancer 44 neo adjuvant 44 Glybera R 44 Multicenter Study 44 Rituximab 44 angiogenesis inhibitor 44 follicular lymphomas 44 diarrhea predominant irritable 44 Simulect 44 selective MHC 44 gadobutrol 44 Confirms Efficacy 44 Curaxin CBLC# 44 Randomized Clinical Trial 44 bevacizumab Avastin R 44 Hb levels 44 MDUFMA 44 bisoprolol 44 Neuvenge 44 Dantrium R 44 Metastatic breast cancer 44 Disinfection Byproducts Rule 44 Embolic 44 smoldering multiple myeloma 44 endoscopic resection 44 Pegylated Interferon 44 RhuDex 44 Coronary Artery Bypass Graft 44 stem cell engraftment 44 artery stenosis 44 BUPHENYL R sodium phenylbutyrate 44 Chronic lymphocytic leukemia 44 Kaplan Meier analysis 44 parathyroid carcinoma 44 antithrombotic therapy 44 FluCAM arm 44 IGF 1R inhibitor 44 AJCC 44 ACTIQ ® 44 transrectal ultrasound guided 44 Orazol 44 Davanat 44 CIN2 + 44 EUC Tier 44 cough dyspnea 44 histologically proven 44 milrinone 44 monocytes macrophages 44 TRAIL R1 44 ocrelizumab 44 Squamous 44 HERCEPTIN 44 descending thoracic 44 Fluorouracil 44 IL2 44 BLyS specific 44 eIF 4E 44 Drug Eluting Coronary Stent 44 Index CDAI 44 epithelial tumors 44 Mucopolysaccharidosis 44 initiated confirmatory Phase 44 HER2 overexpression 44 guaiac 43 CG# oncolytic virus 43 urine albumin 43 neuroendocrine cancers 43 succinate dehydrogenase 43 Enzastaurin 43 imatinib mesylate Gleevec 43 interstitial fibrosis 43 DUROS 43 anterior lumbar interbody fusion 43 Hectorol R 43 Rapeseed Rajasthan #/#.# # 43 NS5A 43 PRIALT 43 lung fibrosis 43 Cardene ® 43 Non Alcoholic Steatohepatitis 43 hemorrhagic cystitis 43 Epoetin 43 Carotid 43 MoxDuo ® 43 pulmonary alveolar 43 cardiac resynchronisation therapy 43 TRISENOX R arsenic trioxide 43 localized prostate 43 Immunohistochemical staining 43 PROTEGE 43 MR Angiography 43 Left Ventricular 43 Abrupt discontinuation 43 Nystatin 43 Diabetic Ulcers 43 deoxy 43 peritumoral brain edema 43 NHDP phase 43 Hybrid HDi 43 ^ sup #m 43 FXIII 43 clinically meaningful improvements 43 relapsed ALL 43 UPDRS Part III 43 moderately emetogenic 43 Inhaled Corticosteroids 43 FLT3 43 Plasma concentrations 43 Esophageal 43 Class IIIb 43 schizophrenia CIAS 43 Chronic Myelogenous Leukemia CML 43 benzothiazole 43 tuberous sclerosis TS 43 VeriStrat 43 myeloproliferative 43 parenterally administered 43 Cardiac Markers 43 Patients Undergoing 43 nimodipine 43 CD# CD# 43 NMDA antagonists 43 aspirin clopidogrel 43 visilizumab 43 Actinic Keratosis 43 ELIM NOx 43 homozygous FH 43 Adenomas 43 Common Toxicity Criteria 43 RAS mutations 43 IIIC 43 CORE Phase 43 Antisoma Plc 43 treat benign prostatic 43 HCV Hepatitis C 43 STAFF WRITER @ tidewaternews.com 43 Tubulin 43 AA amyloidosis 43 ^ Tc 43 Radioimmunotherapy 43 postprocedure 43 Revolade 43 benign prostatic hyperplasia enlarged 43 gastroesophageal junction 43 #.#ng/ml 43 endoluminal stent graft 43 chemotherapy induced thrombocytopenia 43 GSK# [001] 43 Hypotension 43 gastric adenocarcinoma 43 Clot Busting 43 Plecanatide 43 Plus STAARVISC TM 43 erythropoietic 43 idiopathic thrombocytopenic purpura ITP 43 XL# [003] 43 vWF 43 Acute Coronary Syndrome 43 Ventricular Tachycardia 43 Prefilled Syringe 43 Keppra ® 43 transthyretin amyloidosis 43 injectable suspension GABITRIL 43 dihydroergotamine DHE 43 Acute renal failure 43 Thoratec HeartMate 43 PROCHYMAL 43 mycophenolate 43 â ‰ ¥ 43 Hepatotoxicity 43 centrifugal pump 43 injectable diclofenac 43 Zemplar 43 StemEx 43 Tyrosine Kinase Inhibitors 43 IIa clinical 43 HepDirect prodrug 43 HER2 Positive Breast Cancer 43 Arsenic trioxide 43 Contrast Agents 43 mL sec 43 BARACLUDE r 43 capsular polysaccharide